ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · IEX Real-Time Price · USD

6.15

-0.46 (-6.96%)

At close: Jul 19, 2024, 12:00 AM

6.44

+0.29 (4.72%)

Pre-market: Jul 22, 2024, 9:14 AM EDT

ALX Oncology Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	320	742	459	870	3,199	-
Market Cap Growth	202.76%	61.50%	-47.23%	-72.79%	-	-
Enterprise Value	173	569	202	507	2,764	-4
PE Ratio	-	-4.61	-3.72	-10.43	-62.79	-
PS Ratio	-	-	-	-	2706.15	-
PB Ratio	1.95	3.91	1.74	2.40	7.44	-
P/FCF Ratio	-3.96	-5.64	-5.07	-12.66	-83.47	-
P/OCF Ratio	-3.98	-5.69	-5.15	-12.78	-83.54	-
EV/Sales Ratio	-	-	-	-	2338.79	-0.75
EV/EBITDA Ratio	-2.51	-3.59	-1.65	-6.07	-61.03	0.19
EV/EBIT Ratio	-2.50	-3.57	-1.64	-6.07	-60.76	0.19
EV/FCF Ratio	-2.91	-4.32	-2.23	-7.37	-72.14	0.25
Debt / Equity Ratio	0.06	0.05	0.04	-	-	-0.08
Debt / EBITDA Ratio	-0.06	-0.06	-0.08	-	-	-0.29
Debt / FCF Ratio	-0.07	-0.07	-0.10	-	-	-0.37
Quick Ratio	4.89	5.08	9.40	23.78	69.99	1.92
Current Ratio	5.21	5.24	9.57	24.00	70.28	1.97
Asset Turnover	0	0	0	0	0.01	0.44
Interest Coverage	-102.55	-101.75	-517.56	-6420.85	-	-913.71
Return on Equity (ROE)	-90.40%	-79.30%	-40.80%	-21.20%	-39.10%	38.00%
Return on Assets (ROA)	-72.20%	-65.20%	-37.00%	-20.40%	-22.40%	-213.10%
Return on Capital (ROIC)	-101.12%	-85.42%	-46.71%	-23.01%	-10.16%	29.41%
Earnings Yield	-51.87%	-21.68%	-26.88%	-9.59%	-1.59%	-
FCF Yield	-44.07%	-17.75%	-19.74%	-7.90%	-1.20%	-
Buyback Yield / Dilution	-22.66%	-5.62%	-0.97%	-118.05%	-500.86%	-11.84%
Total Shareholder Return	-22.66%	-5.62%	-0.97%	-118.05%	-500.86%	-11.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).